EP3180437A2 - Procédé permettant la production d'alcools à chaîne ramifiée - Google Patents

Procédé permettant la production d'alcools à chaîne ramifiée

Info

Publication number
EP3180437A2
EP3180437A2 EP15750378.0A EP15750378A EP3180437A2 EP 3180437 A2 EP3180437 A2 EP 3180437A2 EP 15750378 A EP15750378 A EP 15750378A EP 3180437 A2 EP3180437 A2 EP 3180437A2
Authority
EP
European Patent Office
Prior art keywords
compound
formula
branched
fuel composition
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15750378.0A
Other languages
German (de)
English (en)
Inventor
Homayoun BAGHERI
María del Mar GONZÁLEZ BARROSO
Antonio MORREALE DE LEÓN
Vicente BERNAL SÁNCHEZ
Sergio GONZÁLEZ BARRERA
Ana ALCALDE BASCONES
Fernando LÓPEZ GALLEGO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repsol SA
Original Assignee
Repsol SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repsol SA filed Critical Repsol SA
Publication of EP3180437A2 publication Critical patent/EP3180437A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L1/00—Liquid carbonaceous fuels
    • C10L1/10—Liquid carbonaceous fuels containing additives
    • C10L1/14—Organic compounds
    • C10L1/18—Organic compounds containing oxygen
    • C10L1/182—Organic compounds containing oxygen containing hydroxy groups; Salts thereof
    • C10L1/1822—Organic compounds containing oxygen containing hydroxy groups; Salts thereof hydroxy group directly attached to (cyclo)aliphatic carbon atoms
    • C10L1/1824—Organic compounds containing oxygen containing hydroxy groups; Salts thereof hydroxy group directly attached to (cyclo)aliphatic carbon atoms mono-hydroxy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L1/00—Liquid carbonaceous fuels
    • C10L1/10—Liquid carbonaceous fuels containing additives
    • C10L1/14—Organic compounds
    • C10L1/18—Organic compounds containing oxygen
    • C10L1/185—Ethers; Acetals; Ketals; Aldehydes; Ketones
    • C10L1/1852—Ethers; Acetals; Ketals; Orthoesters
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L2200/00—Components of fuel compositions
    • C10L2200/04—Organic compounds
    • C10L2200/0407—Specifically defined hydrocarbon fractions as obtained from, e.g. a distillation column
    • C10L2200/0415—Light distillates, e.g. LPG, naphtha
    • C10L2200/0423—Gasoline
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L2270/00—Specifically adapted fuels
    • C10L2270/02—Specifically adapted fuels for internal combustion engines
    • C10L2270/023—Specifically adapted fuels for internal combustion engines for gasoline engines

Definitions

  • the invention relates generally to the uses of biocatalytic processes to obtain branched alcohols.
  • the invention also relates to fuel compositions comprising said alcohols.
  • n-butanol is a better bio-fuel than ethanol due to lower vapour pressure, high energy content and lesser susceptibility to phase separation in the presence of water. Furthermore, n-butanol can be blended at higher concentration than ethanol for use in standard vehicle engines and it does not require automobile manufacturers to compromise on performance to meet environmental regulations, n- Butanol can be obtained from an acetone/n-butanol/ethanol (ABE) mixture produced by the fermentation of carbohydrates by bacteria of the genus Clostridia. However, using fermentation processes, side products are always formed due to the presence of many different enzymes within the organisms; thus, n-butanol cannot be produced as a single fermentation product in Clostridium.
  • ABE acetone/n-butanol/ethanol
  • Enzymes often exhibit a great advantage compared to chemical catalysts because they can accept complex molecules as substrates, catalysing reactions with chiral (enantio-) and positional (regio-) selectivity.
  • the best characterized mechanism for branched chain alcohol production is through the Ehrlich pathway which converts branched chain amino acids into alcohols.
  • the carbon number (up to 5) of the alcohols derived from this type of pathway is limited by the carbon number in the branched chain amino acid pathways.
  • branched chain alcohols Compared to linear alcohols, branched chain alcohols have high octane numbers. However, these alcohols cannot be synthetized economically using native microorganisms. This is a daunting task because a metabolic pathway usually involves the collective function of multiple enzymes which have to be engineered by rational design or directed evolution to perform non-natural activities.
  • the invention relates to a process for obtaining a compound formula (I)
  • Ri is selected from the group consisting of linear or branched Ci-C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear or branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl and wherein R 2 is selected from the group consisting of linear or branched C 2 -C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear, branched C2-C 6 alkynyl, aryl, aryl-alkyl and benzyl; and wherein the sequence of said polypeptide has an identity of at least 45% to the sequences of SEQ ID NO: 1 or SEQ ID NO: 2.
  • the invention relates to an in vivo process for the production of a compound of formula (I)
  • Ri is selected from the group consisting of linear or branched Ci-C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear or branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl and wherein R 2 is selected from the group consisting of linear or branched C 2 -C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear, branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl; wherein the sequence of said polypeptide has an identity of at least 45% to the sequences of SEQ ID NO: 1 or SEQ ID NO: 2.
  • the invention relates to a fuel composition comprising the compound of formula (I). BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 Total Ion Chromatogram (TIC) of 2-ethyl-butyraldehyde reaction with alcohol dehydrogenase from Z. lactis. Identity of compounds eluting at Peak 1 (2-ethyl- butyraldehyde) and Peak 2 (2-ethyl-l-butanol) was confirmed by the corresponding mass spectra.
  • TIC Total Ion Chromatogram
  • FIG. 1 Average mass spectrum of peak 1 (7.88 to 7.98 min) from the reaction of 2-ethyl-butyraldehyde with alcohol dehydrogenase from L. lactis.
  • B Mass spectrum of 2-ethyl-butyraldehyde in the NIST standard reference database.
  • Figure 3 (A) Average mass spectrum of peak 2 (10.05 to 10.10 min) from the reaction of 2-ethyl-butyraldehyde with alcohol dehydrogenase from Z. lactis. (B) Mass spectrum of 2-ethyl- 1 -butanol in the NIST standard reference database.
  • Figure 4 Total Ion Chromatogram of reaction with alcohol dehydrogenase from B. stearothermophilus . Identity of compounds eluting at Peak 1 (2-ethyl-butyraldehyde) and Peak 2 (2-ethyl-l-butanol) was confirmed by the corresponding mass spectra.
  • the authors of the present invention have designed a novel and efficient process for obtaining a long chain branched alcohols by using an enzyme which has a novel biological activity that uses branched long chain aldehydes.
  • the process of the invention provides a non-naturally occurring pathway, which allows the production of 2-ethyl-l-butanol.
  • This compound is useful as fuel additive and it is advantageously useful in fuel compositions due to its high proportion of carbons, low content in oxygen, and high energy density.
  • the invention relates with a process, hereinafter
  • Ri is selected from the group consisting of linear or branched Ci-C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear or branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl and wherein R 2 is selected from the group consisting of linear or branched C 2 -C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear, branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl; and wherein the sequence of said polypeptide has an identity of at least 45% to the sequences of SEQ ID NO: 1 or SEQ ID NO: 2.
  • Ci_-C 6 alkyl group refers to a saturated straight chain or branched non-cyclic hydrocarbon having from 1 to 6 carbon atoms.
  • Representative saturated straight chain alkyls include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n- hexyl; while saturated branched alkyls include isopropyl, sec-butyl, isobutyl, tert-bvXy ⁇ , isopentyl, 2-methylbutyl, 3-methylbutyl, 2-methylpentyl, 3-methylpentyl, 4- methylpentyl, 2,3-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl and the like.
  • Alkyl groups included in compounds of this invention may be optionally substituted with one or more substituents.
  • C2-C6 alkyl group refers to a saturated straight chain or branched non-cyclic hydrocarbon having from 2 to 6 carbon atoms.
  • Representative saturated straight chain and branched alkyls have been cited above and include, without limitation, .
  • R 2 is an alkyl group.
  • C?-C 6 alkenyl group means a straight chain or branched non-cyclic hydrocarbon having from 2 to 6 carbon atoms and having at least one carbon-carbon double bond.
  • Representative straight chain and branched (C2-C6) alkenyls include vinyl, allyl, 1-butenyl, 2-butenyl, isobutylenyl, 1-pentenyl, 2-pentenyl, 3-methyl-l-butenyl, 2-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, and the like.
  • Alkenyl groups may be optionally substituted with one or more substituents.
  • C?-C 6 alkynyl group means a linear chain or branched non-cyclic hydrocarbon having from 2 to 6 carbon atoms and having at least one carbon-carbon triple bond.
  • Representative straight chain and branched (C2-C6) alkynyls include ethyne, propyne, butyne, pentyne, hexyne and the like.
  • Aryl refers to an aromatic hydrocarbon radical such as phenyl, naphthyl or anthracyl.
  • the aryl radical may be optionally substituted by one or more substituents such as hydroxy, mercapto, halo, alkyl, phenyl, alkoxy, haloalkyl, nitro, cyano, carboxy, amino, dialkylamino, aminoalkyl, acyl and alkoxycarbonyl.
  • Aryl- alkyl refers to an alkyl radical, as defined above attached to an aryl radical, as defined above, such as phenyl.
  • Benzyl refers to the group -CH 2 -phenyl.
  • polypeptide having aldehyde reductase activity refers to a polypeptide which catalyzes the NAD(P)H-dependent conversion of branched aldehydes or ketones to their respective alcohols, wherein the term NAD(P)H refers to either NADH or NADPH as the cofactor.
  • the polypeptide having aldehyde reductase activity for use in the present invention is a biological catalyst; thus the polypeptide having aldehyde reductase activity for use in the invention is an enzyme.
  • the mechanism of the catalytic reaction carried out by the polypeptide having aldehyde reductase activity begins with the binding of the NAD(P)H molecule to the polypeptide having aldehyde reductase activity.
  • the aldehyde substrate such as the compound of formula (II)
  • a hydride transfer from the nicotinamide ring to the carbonyl of the substrate and the addition of a proton from an active residue of said polypeptide forms the hydroxyl group of the alcohol product, such as the compound of formula (I).
  • NAD(P) can mean NAD or NADP .
  • the aldehyde reductase activity of the polypeptide having aldehyde reductase activity can be determined by any method known in the art suitable for the determination of the activity of NAD(P)H-dependent aldehyde reductase activity.
  • the enzymatic activity of the polypeptide having aldehyde reductase activity is determined by contacting the polypeptide the activity of which is to be determined with butyraldehyde or 2-ethyl-butyraldehyde as shown in example 1 of the present application.
  • the aldehyde reductase activity of the polypeptide is then determined by monitoring the conversion of NAD(P)H into NAD(P) + , e.g.
  • reaction product e.g. 1-butanol or 2-ethyl-l-butanol when butyraldehyde or 2-ethyl-butyraldehyde are used as substrates, respectively
  • reaction product e.g. 1-butanol or 2-ethyl-l-butanol when butyraldehyde or 2-ethyl-butyraldehyde are used as substrates, respectively
  • Polypeptide having aldehyde reductase activity for use in the present invention include polypeptides having specific activities in the range of at least 0.001, at least 0.01, at least 0.1, at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95 and/or at least 100 mU/mg when using 1-butyraldehyde as substrate or at least 0.001, at least 0.01, at least 0.1, at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70
  • sequence of polypeptide having aldehyde reductase activity has an identity of at least 45% to the sequences of SEQ ID NO: 1 or SEQ ID NO: 2.
  • SEQ ID NO: l corresponds to NAD(+)-Dependent Alcohol Dehydrogenase from
  • Lactococcus lactis and which is encoded b the polynucleotide of SEQ ID NO.3.
  • SEQ ID NO:2 corresponds to the aldehyde dehydrogenase from Bacillus stearothermophilus, and which is encoded b the polynucleotide of SEQ ID NO: 4.
  • the sequence of polypeptide having aldehyde reductase activity has an identity of at least 46%, at least 47%, at least 48%, at least 49%, at least 50%, at least 51%, at least 52%, at least 53%, at least 54%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99% or more to any of the sequences of SEQ ID NO: 1.
  • the above identity value is determined over the complete length of the polypeptides being compared.
  • the sequence of polypeptide having aldehyde reductase activity has an identity of at least 46%, at least 47%, at least 48%, at least 49%, at least 50%, at least 51%, at least 52%, at least 53%, at least 54%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99% or more to any of the sequences of SEQ ID NO: 2.
  • the above identity value is determined over the complete length of the polypeptides being compared
  • Percentage of sequence identity and “percentage homology” are used interchangeably herein to refer to comparisons among polynucleotides or polypeptides, which are determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide or polypeptide sequence in the comparison window may comprise additions or deletions (i.e. gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences.
  • the percentage may be calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
  • the percentage may be calculated by determining the number of positions at which either the identical nucleic acid base or amino acid residue occurs in both sequences or a nucleic acid base or amino acid residue is aligned with a gap to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
  • Those of skill in the art appreciate that there are many established algorithms available to align two sequences.
  • Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith and Waterman, 1981, Adv. Appl. Math. 2:482, by the homology alignment algorithm of Needleman and Wunsch, 1970, J. MoT Biol. 48:443, by the search for similarity method of Pearson and Lipman, 1988, Proc. Natl. Acad. Sci. USA 85:2444, by computerized implementations of these algorithms (e.g., GAP, BESTFIT, FASTA, and TFASTA in the GCG Wisconsin Software Package), or by visual inspection (see generally, Current Protocols in Molecular Biology, F. M. Ausubel et al, eds., Greene Publishing Associates, Inc.
  • BLAST and BLAST 2.0 algorithms which are described in Altschul et al, 1990, J. Mol. Biol. 215: 403-410 and Altschul et al, 1977, Nucleic Acids Res. 3389-3402, respectively as well as the BLASTP algorithm (BLAST Manual, Altschul, S. et al, NCBI NLM NIH Bethesda, Md. 20894, Altschul, S., et al, J., 1990, Mol. Biol. 215:403-410).
  • Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information website.
  • This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score, T, when aligned with a word of the same length in a database sequence.
  • T is referred to as, the neighborhood word score threshold (Altschul et al, supra).
  • M forward score for a pair of matching residues; always >0
  • N penalty score for mismatching residues; always ⁇ 0).
  • a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached.
  • the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
  • the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff and Henikoff, 1989, Proc Natl Acad Sci USA 89: 10915).
  • W wordlength
  • E expectation
  • BLOSUM62 scoring matrix see Henikoff and Henikoff, 1989, Proc Natl Acad Sci USA 89: 10915.
  • Exemplary determination of sequence alignment and percent sequence identity can employ the BESTFIT or GAP programs in the GCG Wisconsin Software package (Accelrys, Madison WI), using default parameters provided, or the ClustalW multiple alignment program (available from the European Bioinformatics Institute, Cambridge, UK), using, in some embodiments, the parameters below.
  • Comparison window refers to a conceptual segment of at least about 20 contiguous nucleotide positions or amino acid residues wherein a sequence may be compared to a reference sequence of at least 20 contiguous nucleotides or amino acids and wherein the portion of the sequence in the comparison window may comprise additions or deletions (i.e. gaps) of 20 percent or less as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences.
  • the comparison window can be longer than 20 contiguous residues, and includes, optionally 30, 40, 50, 100, or longer windows.
  • the process to obtain the compound of formula (I) of the present invention involves starting from a compound of formula (II) and then contacting said compound of formula (II) with the polypeptide having aldehyde reductase activity under conditions suitable for the conversion of the compound of formula (II) into a compound of formula (I), that is to say under conditions which allow the reduction of the carbonyl group of the compound of formula (II) into an alcohol group.
  • the process of the invention is shown in Scheme 1.
  • contacting the compound of formula (II) with the polypeptide having aldehyde reductase activity refers to incubation of said polypeptide and said compound of formula (II) in conditions suitable for the interaction between said compound and said polypeptide; thereby leading to the formation of the compound of formula (I).
  • the conditions required for the polypeptide having aldehyde reductase activity to reduce the aldehyde group of compound (II) to an alcohol group producing the compound of formula (I) include an appropriate ratio between the polypeptide and the substrate in terms of concentration and appropriate conditions of salt, pH, temperature, time of reaction, appropriate concentrations of a reducing agent as the cofactor NADH, appropriate concentrations of the substrate and appropriate concentrations of the polypeptide having aldehyde reductase activity.
  • the first process of the invention is carried in vitro, i.e. by contacting the substrate and the enzyme having aldehyde reductase activity in a reactor, preferably in the absence of any cell.
  • Suitable salt conditions for carrying the process according to the invention include, without limitation, any buffer commonly known such as phosphate buffer, a bicarbonate buffer, a carbonate buffer, Tris buffer, a borate buffer, a succinate buffer, a histidine buffer or a citrate buffer at concentrations of at least 10 mM, at least 20 mM, at least 30 mM, at least 40 mN, at least 50 mM, at least 60 mM, at least 70 mM, at least 80 mM, at least 90 mM, at least 100 mM, at least 200 mM, at least 300 mM or more.
  • the process according to the present invention is carried out in 50 mM phosphate buffer.
  • Suitable pH values for carrying the process according to the invention include, without limitation, values of 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5. In a preferred embodiment, the process is carried out at a pH of 7.5.
  • Suitable temperature conditions for carrying the process according to the invention include, without limitation, about 20°C, about 25°C, about 30°C, about 35°C, about 37°C. In a preferred embodiment, the process is carried out at a temperature between 25°C and 37°C.
  • Suitable reaction times for carrying the process according to the invention can be determined by carrying out small scale reactions and determining the progress of the reaction by measuring the decrease in absorbance at 340 nm. Suitable times include, without limitation, at least 1 ms, at least 1 s, at least 15 s, at least 30 s, at least 1 min, at least 2 min, at least 3 min, at least 4 min, at least 5 min, at least 6 min, at least 7 min, at least 8 min, at least 9 min, at least 10 min, at least 15 min, at least 20 min, at least 25 min, at least 30 min, at least 35 min, at least 40 min, at least 45 min, at least 50 min, at least 55 min, at least 1 h, at least 2h, at least 3 h, at least 4h, at least 5h, at least 6h, at least 7h, at least 8h, at least 9h, at least 10 h or more.
  • Suitable concentrations of the NADPH or NADH cofactor for carrying the process according to the invention include, without limitation, about 10 nM, about 50 nM, about 0.1 mM, about 0.5 mM, about 1 mM, about 5 mM, about 10 mM or more.
  • the term "cofactor" as used herein refers to a non-protein chemical compound that is required for the protein's biological activity.
  • the molecule NADPH acts as cofactor in the process for obtaining a compound of formula (I) defined above.
  • NADH acts as cofactor in the process for obtaining compound of formula (I) defined above.
  • Suitable substrate concentrations for carrying the process according to the invention include, without limitation, about 1 nM, about 5 nM, about 10 nM, about 20 nM, about 30 nM, about 40 nM, about 50 nM, about 100 nM, about 500 nM, about 1 ⁇ , about 10 ⁇ , about 20 ⁇ , about 30 ⁇ , about 40 ⁇ , about 50 ⁇ , about 100 ⁇ , about 500 ⁇ , about 1 mM, about 5 mM, about 10 mM, about 20 mM, about 30 mM, about 40 mM, about 50 mM, about 100 mM or more.
  • the substrate concentration is between 0.1 and 0.5 mM.
  • Suitable concentrations of the polypeptide having aldehyde reductase activity for carrying the process according to the invention include, without limitation, about 1 ⁇ g/mL, about 2 ⁇ g/mL, about 3 ⁇ g/mL, about 5 ⁇ g/mL, about 8 ⁇ g/mL, about 10 ⁇ g/mL, about 20 ⁇ g/mL, about 30 ⁇ g/mL, about 50 ⁇ g/mL, about 75 ⁇ g/mL, about 100 ⁇ g/mL, about 200 ⁇ g/mL, about 300 ⁇ g/mL, about 500 ⁇ g/mL, about 750 ⁇ g/mL, about 1 mg/mL, about 2 mg/mL, about 3 mg/mL, about 5 mg/mL, about 7.5 mg/mL, about 10 mg/mL, about 20 mg/mL, about 30 mg/mL, about 50 mg/mL, about 75 mg/mL, about 100 mg/mL.
  • suitable conditions for obtaining the compound of formula (I) according to the process of the invention comprises using 0.1-0.5 mM of compound (II) as substrate, such as 2-ethyl- butaraldehyde at 25°C-37°C, at pH 7.5, in the presence of 1 mM NADPH as redox cofactor of the reaction and 0.2 mg/mL of the polypeptide having aldehyde reductase activity.
  • substrate such as 2-ethyl- butaraldehyde at 25°C-37°C, at pH 7.5
  • the process of the present invention can be carried out by using a polypeptide having aldehyde reductase activity in pure form in order to obtain high specific activity (which gives a measurement of the enzyme purity in the mixture as the activity of an enzyme per milligram of total protein).
  • the polypeptide having aldehyde reductase activity may be produced in any prokaryotic or any eukaryotic cell, or in an in vitro cell free protein expression system by using methods generally known in the art, based on techniques of recombinant protein production.
  • any cell type can be transformed with a polynucleotide encoding the polypeptide having aldehyde reductase activity (for example, cells can be transformed with a polynucleotide comprising the sequence SEQ ID NO: 3 or SEQ ID NO: 4) or any cell type can be transformed, transfected or infected by a recombinant vector containing the polynucleotide encoding the polypeptide having aldehyde reductase activity; for example animal cells, such as mammalian cells, bird cells, insect cells, etc.; plant cells; yeasts; bacteria; etc. Suitable vector systems are well-known in the art as evidenced by the vast amount of literature and materials available to the skilled person.
  • prokaryotes are preferred for the initial cloning of the nucleic acid which encodes polynucleotides which encode the polypeptide having aldehyde reductase activity (for example, polynucleotides comprising the sequence SEQ ID NO: 3 or SEQ ID NO: 4).
  • Prokaryotes can be also utilized for expression, since efficient purification and protein refolding strategies are available. Strains from E. coli or bacilli such as Bacillus subtilis, or other enterobacteriaceae such as Salmonella typhimurium or Serratia marcesans, and various Pseudomonas species may be used.
  • plasmid vectors containing replicon and control sequences which are derived from species compatible with the host cell are used in connection with these hosts.
  • the vector ordinarily carries a replication site, as well as marking sequences which are capable of providing phenotypic selection in transformed cells.
  • E. coli is typically transformed using pBR322, a plasmid derived from an E. coli species.
  • the pBR322 plasmid contains genes for ampicillin and tetracycline resistance and thus provides easy means for identifying transformed cells.
  • the pBR322 plasmid, or other microbial plasmid or phage must also contain, or be modified to contain, promoters which can be used by the microorganism for expression.
  • promoters most commonly used in recombinant DNA construction include the ⁇ -lactamase (penicillinase) and lactose promoter systems and a tryptophan (trp) promoter system. While these are the most commonly used, other microbial promoters have been discovered and utilized, and details concerning their nucleotide sequences have been published, enabling a skilled worker to ligate them functionally with plasmid vectors. Certain genes from prokaryotes may be expressed efficiently in E. coli from their own promoter sequences, precluding the need for addition of another promoter by artificial means.
  • eukaryotic microbes such as yeast may also be used. Saccharomyces cerevisiae or common baker's yeast is the most commonly used among eukaryotic microorganisms, although a number of other strains are commonly available.
  • Suitable promoter sequences in yeast vectors include the promoters for 3- phosphoglycerate kinase or other glycolytic enzymes, such as enolase, glyceraldehyde- 3-phosphate dehydrogenase, hexokinase, pyruvate decarboxylase, phosphofructokinase, glucose-6-phosphate isomerase, 3-phosphoglycerate mutase, pyruvate kinase, triosephosphate isomerase, phosphoglucose isomerase, and glucokinase.
  • 3- phosphoglycerate kinase or other glycolytic enzymes such as enolase, glyceraldehyde- 3-phosphate dehydrogenase, hexokinase, pyruvate decarboxylase, phosphofructokinase, glucose-6-phosphate isomerase, 3-phosphoglycerate mutase, pyruv
  • the termination sequences associated with these genes are also ligated into the expression vector 3' of the sequence desired to be expressed to provide polyadenylation of the mR A and termination.
  • Other promoters which have the additional advantage of transcription controlled by growth conditions are the promoter region for alcohol dehydrogenase-2, isocytochrome C, acid phosphatase, degradative enzymes associated with nitrogen metabolism, and the aforementioned glyceraldehyde-3 -phosphate dehydrogenase, and enzymes responsible for maltose and galactose utilization.
  • Any plasmid vector containing a yeast-compatible promoter, origin of replication and termination sequences is suitable.
  • the polypeptide having aldehyde reductase activity additionally comprises a peptide to facilitate its purification.
  • peptide to facilitate its purification refers to a peptide useful for isolating or purifying the polypeptide having aldehyde reductase activity which binds to the N- or C-terminus end. Said peptide is thus capable of binding one or more ligands of an affinity matrix, such as an affinity chromatography.
  • His-tag histidine tag
  • His6 or H6 six histidine residues
  • peptides include, but are not limited to, Arg-tag, FLAG-tag, Strep-tag, an epitope capable of being recognized by an antibody, such as c-myc-tag (recognized by an anti- c-myc antibody), SBP-tag, S-tag, calmodulin-binding peptide, cellulose-binding domain, chitin-binding domain, glutathione S-transferase-tag, maltose-binding protein, NusA, TrxA, DsbA, Avi-tag, etc.
  • cells are lysed and the tagged bait together with bound proteins.
  • the polypeptide is isolated using a specific chemical or biological ligand linked to a solid support. Eluted proteins can be separated by any suitable method known in the art such as chromatography or electrophoresis methods.
  • the starting compound for the process of the present invention is the compound of formula (II).
  • Ri is a linear Ci-C 6 alkyl group and R 2 is a linear C 2 -C 6 alkyl group.
  • Ri is a methyl group and R 2 is a linear C 2 -C 6 alkyl group.
  • Ri is a linear Ci-C 6 alkyl group and R 2 is an ethyl group.
  • R 2 is an ethyl group and Ri is a linear Ci-C 6 alkyl group, more preferably a methyl group.
  • Ri is a methyl group and R 2 is an ethyl group.
  • the starting compound is defined by formula (II) wherein Ri is a methyl group.
  • the starting compound is defined by formula (II), wherein R 2 is an ethyl group.
  • the starting compound is defined by formula (II), wherein Ri is a methyl group and R 2 is an ethyl group, named 2-ethyl-butyraldehyde.
  • the process of the invention allows obtaining a compound of formula (I) wherein Ri is a methyl group and R 2 is an ethyl group, named 2-ethyl-butanol.
  • the process of this particular embodiment of the process of the invention is shown in scheme II.
  • the compounds of formula (II), can be obtained by any method known by the person skilled in the art by using standard synthetic methods known in the art or by acquiring said compound from any supplier of chemical compounds or from a chemical library such small organic molecule libraries.
  • the polypeptide having aldehyde reductase activity comprises at least one GroES-like alcohol dehydrogenase domain and at least a Zinc binding dehydrogenase domain.
  • GroES-like alcohol dehydrogenase domain or "GroEs-like domain” as used herein, refers to a domain as shown under accession number PF08240 in the Pfam database which is a catalytic domain having a GroES-like structure. Proteins with a GroES fold structure have a highly conserved hydrophobic core and a glycil-aspartate dipeptide which is thought to maintain the fold.
  • Zinc binding dehydrogenase domain refers to a domain having accession number PF00107 in the Pfam database and which forms the cofactor binding domain of the alcohol dehydrogenase enzyme. This domain is normally found towards the C-terminus and structural studies indicate that it forms a classical Rossmann fold that reversibly binds nicotinamide adenine dinucleotide (NAD+).
  • NAD+ nicotinamide adenine dinucleotide
  • polypeptide having aldehyde reductase activity has the sequence selected from SEQ ID NO: 1 and SEQ ID NO: 2.
  • the invention in another aspect, relates to an in vivo process, hereinafter second process of the invention" for the production of a compound of formula (I)
  • Ri is selected from the group consisting of linear or branched Ci-C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear or branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl and wherein R 2 is selected from the group consisting of linear or branched C 2 -C 6 alkyl, linear or branched C 2 -C 6 alkenyl and linear, branched C 2 -C 6 alkynyl, aryl, aryl-alkyl and benzyl; and wherein the sequence of said polypeptide has an identity of at least 45% to the sequences of SEQ ID NO: 1 or SEQ ID NO: 2.
  • the contact between said compound of formula (II) and the polypeptide having aldehyde reductase activity is carried out in a genetically modified microorganism which expresses the polypeptide having an aldehyde reductase activity and which contains the compound of formula (II).
  • genetically modified microorganism refers to a microorganism whose genetic material has been altered using genetic engineering techniques.
  • the second process of the invention relates to obtaining compound of formula (I) by means of a genetically modified microorganism capable of producing said compound of formula (I) characterized in that said genetically modified microorganism expresses (i) a polypeptide having an aldehyde reductase activity as defined above and (ii) contains the compound of formula (II), compared to a corresponding non-modified control microorganism of the same strain.
  • the polypeptide having aldehyde reductase activity may be encoded by a gene found in the genome of the microorganism or may result from the introduction of a polynucleotide encoding said polypeptide into said microorganism.
  • the polynucleotide encoding a polypeptide having an aldehyde reductase activity can be introduced into the microorganisms in any suitable form, e.g. comprised in a vector, a plasmid or as naked nucleic acid.
  • the polynucleotide introduced into the microorganism may then be exogenous, on a vector/plasmid within the microorganisms [i.e. outside of the microbial chromosome(s)], or it may be incorporated into the microbial chromosome(s) by random (ectopic) or homologous recombination or any other suitable method as known in the art.
  • the polypeptide encoding the polynucleotide having an aldehyde reductase can be codon-optimized, or modified to be optimized for expression in the recombinant microorganism.
  • the genetically modified microorganism is cultured under appropriate conditions that allow the expression of the polypeptide having aldehyde reductase activity; and thereby producing the compound of formula (I).
  • the person skilled in the art will understand that said conditions vary depending on the microorganism that is genetically transformed to be cultured.
  • Suitable culture media for appropriate growth of different microorganisms are well known in the art; for example if the process of the invention is carried out in a Gram-negative genetically modified microorganism the culture media can comprise 1.5 g/L of KH 2 PO 4 , 4.54 g/L of K 2 HP0 4 trihydrate, 4 g/L of (NH 4 ) 2 S0 4 , 0.15 g/L of MgS0 4 heptahydrate, 20 g/L of glucose, 200 mM of Bis-Tris buffer (pH 7.2), 1.25, and 1.25 mL/L of a vitamin solution.
  • the vitamin solution can comprise, for example, 0.42 g/L of riboflavin, 5.4 g/L of pantothenic acid, 6 g/L of niacin, 1.4 g/L of pyridoxine, 0.06 g/L of biotin, and 0.04 g/L of folic acid.
  • polypeptide having aldehyde reductase activity contains a GroES-like alcohol dehydrogenase domain having accession number PF08240 in the Pfam database and a Zinc-binding dehydrogenase domain having accession number PF00107 in the Pfam database.
  • the polypeptide having aldehyde reductase activity has the sequence selected from SEQ ID NO: 1 and SEQ ID NO: 2.
  • the genetically modified organism contains the compound of formula (II).
  • the expression "contain the compound of formula (II)" as used herein, means that said compound of formula (II) is endogenously produced by the microorganism. Said expression also encompasses that said compound of formula (II) is not endogenously produced by the microorganism and that said compound has exogenously introduced into the cell.
  • Ri is a methyl group.
  • R 2 is an ethyl group.
  • the compound of formula (II) is 2-ethyl- butanaldehyde.
  • the genetically modified microorganism has been previously contacted with the compound of formula (II).
  • the term "contacting" the cell with the compound of formula (II) is understood, according to the present invention, as any possible way of introducing said compound into said microorganism. Suitable methods for introducing the compound of formula (II) are well known in the art. In the context of the invention, due to the low molecular weight of compound (II), it is sufficient to add said compound to the culture medium.
  • any suitable microorganism can be genetically transformed in order to express the polypeptide having aldehyde reductase activity.
  • said microorganism is selected from the group comprising bacterium, yeast and fungus.
  • the yeasts and filamentous fungi include Pichia sp. (for example, P. pastoris, P . finlandica, P. trehalophila, P. koclamae, P. membranaefaciens, P. minuta, P. opuntiae, P. thermotolerans, P. salictaria, P. guercuum, P. pijperi, P. stiptis, P. methanolica), Saccharomyces (S.
  • Hansenula polymorpha Candida, Kloeckera, Torulopsis, and Rhodotorula, Hansenula, Kluyveromyces sp. (Tor example, Kluyveromyces lactis), Candida albicans, Aspergillus sp. (Tor example, Aspergillus nidulans, Aspergillum niger, Aspergillus oryzae), Trichoderma reesei,Chrysosporium luchiowense, Fusarium sp. (for example, Fusarium gramineum, Fusarium venenatum), Physcomitrella patens.
  • bacteria examples include Escherichia coli, Shigella spp., Bacillus cereus, Yersinia pestis, Pseudomonas spp., Bordetella pertussis, Borrelia burgdorferi, Campylobacter pylori, Chlamydia trachomatis, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Lactobacillus acidophilus, Legionella pneumophila, Listeria monocytogenes, Mycobacterium diphtheriae, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, Salmon
  • said microorganism is selected from the group consisting of a bacterium of the genus Clostridium spp., Bacillus spp., Streptomyces spp., or Escherichia spp., yeast of the genus Saccharomyces spp., Pichia spp, Schhizosaccharomyces spp., Candida spp., or Hansenula spp., and a fungus of the genus Aspergillus spp. or Trichoderma spp.
  • said microorganism is Escherichia coli.
  • the gene encoding the aldehyde reductase can be placed under the control of a constitutive promoter or under the control of an inducible promoter.
  • Suitable promoters for use in the microorganism for use in the second process of the invention have been described above in the context of the first process of the invention and include the ⁇ - lactamase (penicillinase) and lactose promoter systems and a tryptophan itrp) promoter system.
  • the promoter is the lactose promoter and the induction is carried out using isopropyl-P-D-l-thiogalactopyranoside (IPTG).
  • induction is carried out using 0.01 to 1 mM IPTG, more preferably 1 mM IPTG. Induction is carried out during the time and at the temperature needed to achieve sufficient aldehyde reductase activity in the cell. In a preferred embodiment, induction is carried out at 18-37°C, preferably at 25°C. In another embodiment, induction is carried out for 1 to 16 h, preferably during 5 h. In a preferred embodiment, induction is carried out using IPTG at 25°C for 5 h. The cell culture is then placed in contact with the substrate. The concentration of the substrate during the contacting step is not particularly limiting.
  • Suitable substrate concentrations for carrying the process according to the invention include, without limitation, about 1 nM, about 5 nM, about 10 nM, about 20 nM, about 30 nM, about 40 nM, about 50 nM, about 100 nM, about 500 nM, about 1 ⁇ , about 10 ⁇ , about 20 ⁇ , about 30 ⁇ , about 40 ⁇ , about 50 ⁇ , about 100 ⁇ , about 500 ⁇ , about 1 mM, about 5 mM, about 10 mM, about 20 mM, about 30 mM, about 40 mM, about 50 mM, about 100 mM or more.
  • the substrate concentration is 5 to 200 mM, preferably 5 mM.
  • the substrate is butyraldehyde and is used at 5 mM.
  • the cells are concentrated prior to the contacting step.
  • the concentration of the cells is carried out by centrifugation and resuspension of the cell pellet in a volume which results in an optical density which is higher than the optical density of the starting culture.
  • the cells are resuspended at a cell density of about 0.5 to 10 optical density units, preferably at a cell density of about 4.
  • Resuspension of the cells is carried out typically in a buffer solution in the presence of a carbon source.
  • the buffer solution is a phosphate buffer at a pH of about 5 to 8.5, preferably at a pH of 7.5.
  • the carbon source is glucose.
  • glucose is added at a concentration of 5 to 200 mM, more preferably 40 mM.
  • Suitable reaction times for carrying the process according to the invention can be determined by performing a time course experiments wherein samples of the culture are taken at regular intervals and the amount of product formed determined by analysing the supernatant of the culture medium. Said detection is carried out preferably by chromatography (preferably gas chromatography) coupled to mass spectrometry. Suitable times for the in vivo process include, without limitation, between 1 h to 480 h, preferably between 2 h and 240 h, more preferably between 5 and 120 h and even more preferably between 24-48 h.
  • the culture is carried out under aerobic conditions under shaking and at a temperature between 18 to 45°C, more preferably at 25°C.
  • the second process of the invention comprises an additional step comprising recovering the compound of formula (I) from the culture and/or from said genetically modified microorganism by any suitable method known by the person skilled in the art.
  • the compound of formula (I) can be recovered from the microorganism by a single lysis step so that all biological membranes are disrupted, including the cell membrane and the mitochondrial membranes, thereby obtaining a whole cell lysate which can then be further processed in order to purify the compound of formula (I).
  • the step of lysing the cells can be achieved by any convenient means, including, but not limited to, heat-induced lysis, adding a base, adding an acid, using enzymes such as proteases and polysaccharide degradation enzymes such as amylases, using ultrasound, mechanical lysis (i.e., subjecting the biomass to pressure sufficient to lyse the cells, termed "pressing"), using osmotic shock, infection with a lytic virus, or expression of one or more lytic genes. Lysis is performed to release intracellular molecules which have been produced by the cell.
  • pressing mechanical lysis
  • osmotic shock infection with a lytic virus
  • lytic genes expression of one or more lytic genes.
  • Lysis is performed to release intracellular molecules which have been produced by the cell.
  • Each of these methods for lysing cells can be used as a single method or in combination simultaneously or sequentially. The extent of cell disruption can be observed by microscopic analysis.
  • the lysate or extract can be isolated or extracted from a cell by adding a base to a suspension containing the cells.
  • the base should be strong enough to hydrolyze at least a portion of the protein compounds of the cells.
  • Bases which are useful for solubilizing proteins are known in the state of the art.
  • Exemplary bases which are useful in the present invention include, but are not limited to, hydroxides, carbonates and bicarbonates of lithium, sodium, potassium, calcium, and mixtures thereof.
  • the lysate or extract can be isolated or extracted from a cell by using an enzyme.
  • Suitable enzymes to be used according to the present invention include but are not limited to, proteases and polysaccharide-degrading enzymes such as lysozyme, hemicellulase, pectinase, cellulase, driselase, proteases, chymotrypsin, and proteinase K. Any combination of a protease and a polysaccharide-degrading enzyme can also be used.
  • the lysate or extract can be isolated or extracted from a cell using an expeller press. In this process, cells are forced through a screw-type device at high pressure, lysing the cells and causing the intracellular product to be released and separated from the protein and fiber (and other components) in the cell.
  • the lysate or extract can be isolated or extracted from a cell by using ultrasound, i.e., sonication.
  • ultrasound i.e., sonication.
  • cells can also be lysed with high frequency sound. The sound can be produced electronically and transported through a metallic tip to an appropriately concentrated cellular suspension. This sonication (or ultrasonication) disrupts cellular integrity based on the creation of cavities in cell suspension.
  • the lysate or extract can be isolated or extracted from a cell by mechanical lysis. Cells can be lysed mechanically and optionally homogenized to facilitate collection of the product.
  • a pressure disrupter can be used to pump a cell containing slurry through a restricted orifice valve. High pressure is applied, followed by an instant expansion through an exiting nozzle.
  • cell disruption is accomplished by three different mechanisms: impingement on the valve, high liquid shear in the orifice, and sudden pressure drop upon discharge, causing an explosion of the cell.
  • the method releases intracellular molecules.
  • a ball mill can be used.
  • cells are agitated in suspension with small abrasive particles, such as beads. Cells break because of shear forces, grinding between beads, and collisions with beads. The beads disrupt the cells to release cellular contents. Cells can also be disrupted by shear forces, such as with the use of blending (such as with a high speed or Waring® blender), the french press, or even centrifugation in case of weak cell walls, to disrupt cells.
  • the lysate or extract can be isolated or extracted from a cell by applying an osmotic shock.
  • the lysate or extract can be isolated or extracted from a cell by infecting the cells with a lytic virus.
  • viruses to lyse cells suitable for use in the present invention are well known by the person skilled in the art.
  • compound I can be extracted from the cell by contacting the cells with permeabilizmg agents. Said permeabilizmg agents are chemical compounds which greatly affect the cell envelope (in general) and even the outer membrane structure of cells, and low (or even high) molecular weight compounds may leak out of the cell (e.g. cofactors).
  • permeabilizmg agents are known by the person skilled in the art and include, but are not limited to ionic and non ionic detergents (Triton XI 00, Tween 20), organic solvents (acetone, ethanol, methanol, isopropyl alcohol, toluene, lactic acid), chelating agents (EDTA) and certain polycationic substances (such as polyethylenimine, polymyxin and its derivatives, polylysines and protamine). These compounds compromise cell viability, but also affect bioprocess performance. In bioprocesses in which growth and biotransformation are uncoupled, cell proliferation is not necessary to maintain productivity.
  • ionic and non ionic detergents Triton XI 00, Tween 20
  • organic solvents acetone, ethanol, methanol, isopropyl alcohol, toluene, lactic acid
  • EDTA chelating agents
  • polycationic substances such as polyethylenimine, polymyxin and its derivatives, polyly
  • compound I can be extracted from the cell by expressing in the cell membrane transport systems able to export organic compounds, namely said compound I.
  • membrane transport proteins are known by the person skilled in the art and include, but are not limited to periplasmic porins, multidrug efflux pumps and solvent efflux pumps.
  • the invention relates to a fuel composition, hereinafter "the fuel composition of the invention” comprising the compound of formula (I), wherein the compound of formula (I) is as defined above.
  • the invention relates to the use of the compound of formula (I) as fuel.
  • the invention relates to a fuel composition comprising the compound of formula (I) obtained according to the method of the invention. All embodiments mentioned above regarding the processes of the invention are equally applicable to the fuel composition comprising the compound of formula (I) obtained according to the process defined in the first or in the second aspect of the invention.
  • Ri is a linear Ci-C 6 alkyl group and R 2 is a linear C 2 - C 6 alkyl group. In a more preferred embodiment, Ri is a methyl group and R 2 is a linear C 2 -C 6 alkyl group. In yet another embodiment, Ri is a linear Ci-C 6 alkyl group and R 2 is ethyl group. In another embodiment, Ri is a methyl group and R 2 is ethyl group. In yet another embodiment, Ri is a methyl group. In another particular embodiment, R 2 is an ethyl group. In a still more particular and preferred embodiment of the invention, Ri is a methyl group and R 2 is an ethyl group, named 2-ethyl-butyraldehyde.
  • fuel refers to any material that store potential energy in forms that can be practicably released and used for work or as heat energy.
  • fuel includes solid fuels, liquid fuels and gaseous fuels.
  • Solid fuels refers to various types of solid material that are used as fuel to produce energy and provide heating, usually released through combustion, solid fuels include wood, charcoal, peat, coal, hexamine fuel tablets, and pellets made from wood, corn, wheat, rye and other grains.
  • Liquid fuels are combustible or energy-generating molecules than can be harnessed to create mechanical energy, usually producing kinetic energy; they also must tale the shape of the container.
  • Liquid fuels include but are not limited to diesel, gasoline, kerosene, liquefied petroleum gas (LPG), coal tar, naphtha and ethanol.
  • Gaseous fuels include but are not limited to hydrogen, propane, coal gas, water gas, blast furnace gas, coke oven gas and compressed natural gas (CNG). In a preferred embodiment, by fuel is meant liquid fuels.
  • the compound of formula (I), particularly 2-ethyl-l-butanol, is preferably obtained by the process defined in the first aspect of the present invention.
  • the invention relates to the use of the compound of formula (I) as a fuel additive.
  • fuel additive refers to a compound which is added to fuels to improve performance (such as increasing octane rating) or meet governmental or established regulations. In general terms, fuel additives are added in minor amounts.
  • Illustrative examples of fuel additives include but are not limited to oxygenates, detergents, dispersants, lubricant agents, cetane improvers, cold flow improvers, metal deactivators, demulsifiers, defoamants, dyes, corrosion inhibitors and the like.
  • the compound of formula (I), particularly 2-ethyl-butanol may be added to a fuel composition such as gasoline or diesel fuel or mixtures thereof.
  • a fuel composition such as gasoline or diesel fuel or mixtures thereof.
  • the compound of formula (I) is compatible with ordinary fuel systems and does not require any modification to an engine before use.
  • the compound of formula (I) used as fuel or as fuel additive and may be used in internal combustion engines; thereby, the compound of formula (I) may be used for road motor transport vehicles, private or commercial passenger vehicles, marine engines, train engines, marine application (such as jet skis, outboard motors and inboard motors), recreational application (such as snowmobiles, mopeds and motorcycles), residential application (such as lawnmowers, string trimmers and chain saws), powered constructions equipment or potable water or stationary powered electric generators.
  • the fuel composition comprises from 0.1% to 40% (v/v) of said compound of formula (I).
  • v/v refers to volume percent concentration defined as [(volume of solute)/(volume of solution)] x 100%.
  • the fuel composition of the invention comprises from 3% to 15% (v/v) of said compound of formula (I).
  • said fuel composition comprises from 5% to 10% (v/v) of said compound of formula (I).
  • the fuel composition comprises 0.2%>, 0.3%>, 0.4%>, 0.5%>, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% of said compound of formula (I).
  • the components of the fuel composition are mixed (or blended) in appropriated proportions so that the fuel composition meets the quality specification established by the governments.
  • Typical quality specifications of fuel compositions include but are not limited to density at 15°C, sulphur content, vapour pressure, distillation curve, olefins content, aromatic hydrocarbons content, benzene content, Research Octane Number and Motor Octane Number. Therefore, the fuel composition is made by means of using any suitable fuel blending process known in the art.
  • the fuel composition of the invention further comprises at least one hydrocarbon.
  • hydrocarbon refers to an organic compound consisting of hydrogen and carbon atoms. Hydrocarbons from which one hydrogen atom has been removed are functional groups, called hydrocarbyls. Hydrocarbons are classified into alkanes, unsaturated hydrocarbons which include alkenes and alkynes, cycloalkanes and aromatic hydrocarbons. Hydrocarbons can be gases (such as methane and propane), liquid (such as hexane and benzene), waxes or low melting solid (such as paraffin wax and naphthalene) or polymers (such as polyethylene, polyethylene and polystyrene).
  • Hydrocarbons of the fuel composition of the invention are typically derived from petroleum.
  • the refining process of crude oil or petroleum leads to obtaining different complex mixtures of hydrocarbons called naphtha.
  • naphtha is defined as the fraction of hydrocarbons in petroleum boiling between 30°C and 200°C.
  • said at least one hydrocarbon is selected from the group consisting of an aromatic hydrocarbon, paraffin, an olefin, a naphthene and combinations thereof.
  • aromatic hydrocarbon is meant as hydrocarbons that have at least one aromatic ring.
  • aromatic hydrocarbons include but are not limited to benzene, toluene, ethylbenzene, / ⁇ -xylene, m-xylene, mesitylene, durene, 2- phenylhexane, biphenyl, phenol, aniline and nitrobenzene.
  • paraffin refers to any of the saturated hydrocarbons having the general formula C n H 2n+2 (C being a carbon atom and H being a hydrogen atom).
  • olefin refers to any unsaturated hydrocarbon containing one or more pairs of carbon atoms linked by a double bond.
  • the olefins are cyclic or acyclic (aliphatic), depending on if the double bond is located between carbon atoms forming part of a cyclic (closed ring) or of an open-chain grouping, respectively.
  • naphthene or "cycloalkane”, as used herein refers to hydrocarbon compounds having one or more rings of carbon atoms in the chemical structure of the molecule.
  • the general formula of naphthene is C n H 2 ( n+ i_ g ), wherein n is the number of carbon atoms, and g is the number of rings in the molecule.
  • the fuel composition of the invention comprises from 40% to 99.9% (v/v) of said at least one hydrocarbon.
  • the fuel composition of the invention comprises the compound of formula (I) as defined above and 40% (v/v) of said at least one hydrocarbon.
  • the fuel composition of the invention comprises the compound of formula (I) as defined above and 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 99% or 99.9%) (v/v) of said at least one said hydrocarbon.
  • the fuel composition of the invention comprises more than one hydrocarbon.
  • An Illustrative example of a combination of said hydrocarbon composition may comprise benzene, at least one aromatic hydrocarbon different from benzene and an olefin.
  • the percentage of any compound can vary according to different specification.
  • the mixture of hydrocarbons may be blended forming a composition according to the present invention having 40% (v/v) of hydrocarbons content, wherein 18% (v/v) are olefins, 35% (v/v) are aromatic hydrocarbons including benzene and 1% (v/v) benzene.
  • the determination of the hydrocarbon content on the fuel composition of the invention can be determined by any suitable method known in the art.
  • the hydrocarbon content on the fuel composition of the invention is measured by a multidimensional gas chromatography method.
  • said content is determined by the internal standard procedure ISO 22854. Said procedure specifies the gas chromatographic method for the determination of saturated, olefmic and aromatic hydrocarbons in automotive motor gasoline and automotive ethanol fuel. Additionally, the benzene content, oxygenate compounds and the total oxygen content can be determined. This international standard defines two procedures, A and B.
  • Procedure A is applicable to compositions with a total volume fraction of aromatics up to 50%, a total volume fraction of olefins from about 1.5% up to 30%; a volume fraction of oxygenates from 0.8% up to 15%; a total mass fraction of oxygen from about 1.5% to about 3.7%; and a volume fraction of benzene up to 2%.
  • the system may be used for a volume fraction of ethers with 5 or more carbons up to 22%.
  • this method may also be applied to other hydrocarbon streams having similar boiling ranges such as naphthas and reformates.
  • Procedure B describes the procedure for the analysis of oxygenated groups.
  • the composition is diluted with an oxygenate- free component to lower the oxygenate content to a value below 20% (v/v) before the analysis by gas chromatographic. If the oxygenated component content is known, the dilution factor can be established accordingly. If, on the contrary, it is unknown, it is advised to use a dilution 4: 1 when analysing the sample.
  • the fuel composition of the invention further comprises from 0.1% to 22% (v/v) of ethyl tert-butyl ether (ETBE), ethanol or methyl tert-butyl ether (MTBE).
  • EBE ethyl tert-butyl ether
  • MTBE methyl tert-butyl ether
  • ETBE ethyl tert-butyl ether
  • 2-ethoxy-2-methyl-propane ethyl tert-butyl ether
  • ETBE is typically produced from the catalytic etherification of ethanol with C 4 branched olefins such as isobutene.
  • ethanol refers to a 2-carbon alcohol, having the formula C 2 H 6 0. It is used as gasoline additive to increase the octane number.
  • Ethanol can be chemically synthesized or, alternatively can be obtained from cellulose biomass materials, starch crops, paper or rice-straw by microbiological fermentation processes.
  • methyl tert-butyl ether 2-methoxy-2-methylpropane
  • MTBE is an organic compound using as gasoline additive to raise the octane number. MTBE is typically produced via the chemical reaction of methanol and isobutylene.
  • the total oxygen content in the composition of the invention is not more than 3.7% (w/w).
  • total oxygen content refers to the ratio of the mass of oxygen to the total mass amount of the fuel composition of the invention.
  • the determination of the oxygen content on the fuel composition of the invention can be carried out by method known in the art.
  • the oxygen content is determined using the methods described by the European Normatives EN1601, EN13132 and EN ISO 22854.
  • the fuel composition of the invention further comprises up tol500 mg/kg sulphur.
  • Sulphur is a naturally occurring compound in crude oil.
  • the content in sulphur is from 150 to 300 mg/kg.
  • the composition of the invention comprises from 10 to 12 mg/kg sulphur.
  • the fuel composition of the invention comprises 10 mg/kg sulphur, 50 mg/kg sulphur, 80 mg/kg sulphur, 150 mg/kg sulphur, 300 mg/kg sulphur, 500 mg/kg sulphur or 1000 mg/kg sulphur.
  • the determination of sulphur contents in the fuel composition of the invention can be carried out by any suitable method such as ASTM (Society for testing Materials standard) D5453, which uses ultraviolet fluorescence to measure sulphur concentrations in liquid hydrocarbons. Other specified methods for testing sulphur contents may also be used such X-ray spectrometry.
  • ASTM Society for testing Materials standard
  • D5453 which uses ultraviolet fluorescence to measure sulphur concentrations in liquid hydrocarbons.
  • Other specified methods for testing sulphur contents may also be used such X-ray spectrometry.
  • the fuel composition of the invention has a Reid vapor pressure up to 103 kPa.
  • the term "Reid vapor pressure" as used herein refers to the absolute vapor pressure exerted by a liquid at 100°F (37.8°C). The matter of vapor pressure is important relating to the function and operation of gasoline powered, especially carbureted, vehicles. High levels of vaporization are desirable for winter starting and operation and lower levels are desirable in avoiding vapor lock during summer heat. Fuel cannot be pumped when there is vapor in the fuel line (summer) and winter starting will be more difficult when liquid gasoline in the combustion chambers has not vaporized. Typically, the Reid vapor pressure of a fuel composition is from.
  • the fuel composition, of the invention has a Reid vapor pressure from 55 to 58 kPa.
  • the fuel composition of the invention has a Reid vapor pressure of 45 kPa, 50 Kpa, 55 kPa, 60 kPa, 65 kPa, 70 kPa, 75 kPa, 80kPA, 85 kPa, 90 kPa, 95 kPa or 100 kPa.
  • the Reid vapor pressure can be determined by any suitable test known in the state of the art such as the ASTDM D6378, ASTM D5188, ASTM D6377, ASTM D6897 and ASTM-D5 1 1 test.
  • the Reid vapor pressure is determined by the ASTM D5191 method. Said method covers the use of automated vapor pressure instruments to determine the total vapor pressure exerted in vacuum by air-containing volatile, liquid petroleum products, including automotive spark ignition fuels with or without oxygenates.
  • the calculation of the vapor pressure according to said test is determined by the equation (0.965 X)-A, wherein the X parameter corresponds with the measurement of total vapor pressure, in units consistent with A; and A has the 3.78 kPa value.
  • the fuel composition of the invention has a density at 15°C up to 775 kg/nf.
  • density refers to a mass per unit volume i.e. mass of a substance divided by its volume as a specific temperature.
  • the density of the fuel composition of the invention can be measured by any suitable method known in the state of the art.
  • the density of the fuel composition of the invention is determined by the ASTM D4052 test. This test method covers the determination of the density or relative density of petroleum distillates (for example gasoline, gasoline-oxygenate blends, diesei, jet fuel, base stocks) and viscous oils that can be handled in a normal fashion as liquid at test temperatures between 15°C and 35°C by means of a density meter.
  • the fuel composition of the invention has a Research Octane Number from. 83 to 98 and/or a Motor Octane Number from 75 to 85.
  • octane rating refers to a standard measure of the performance of motor or aviation fuel. The higher the octane number, the more compression the fuel can withstand. High compressibility of the fuel matters in proportion to the compression the engine is designed to generate.
  • the most common type of octane rating is the Research Octane Number (RON), which is determined by running the fuel in a test engine with a variable compression ratio under controlled conditions, and comparing the results with those mixtures of isooctane and n- heptane.
  • the motor octane number is another type of octane rating which provides a measure of how the fuel behaves when under load, as it is determined at 900 rpm engine speed, instead of the 600 rpm for RON.
  • MON testing uses a similar test engine to that used in RON testing, but with a preheated fuel mixture, higher engine speed, and variable ignition timing to further stress the fuel ' s knock resistance.
  • the fuel composition of the invention has a RON of
  • composition of the invention has a RON of
  • the fuel composition of the invention has a MON of
  • composition of the invention has a MON of
  • any method can be used to determine the RON and MON of the fuel composition of the invention.
  • the RON and MON of a spark-ignition engine fuel is determined using a standard test engine and operating conditions to compare its knock characteristics with those of primary reference fuel blends of known octane number. Compression-ratio and fuel-air ratio are adjusted to produce standard knock intensity for the sample fuel, as measured by a specific electronic denotation meter instrument system. The specific procedure for the RON can be found in ASTM D2699 and the MON can be found in ASTM D2700.
  • a fuel composition according to the present invention is exemplified in Example 4 of the present application.
  • the fuel composition of the invention comprises suitable components for gasoline blends.
  • Conventional gasoline components include but are not limited to reformed naphtha, debenzeneized reformed naphtha, fluid catalytic cracking naphtha, isopentane, ETBE, isomerate, alkylate, butanes, MTBE, hydrocracker naphtha and straight run naphtha.
  • Other components that can be included in the gasoline are the ones derived from Fischer-Tropsch processes, using biomass, natural gas, coal or other raw materials, from pyrolysis of biomass or other raw materials, and other oxygenates (alcohols, ethers, etc.) among others.
  • a refinery may have from butane, the most volatile component to heavy naphtha and include several gasoline naphthas from crude distillation, catalytic cracking and thermal processing units in addition to alkylate, isomerate and reformate.
  • Gasoline may blended to meet different quality standards as has been detailed above. These standards include limits to some properties, such as vapour pressure;% volume evaporated at 70°C, 100°C and 150°C, final boiling point, sulfur content; color; stability; aromatic content; olefin content; octane measurements; and other local government or market restrictions.
  • EXAMPLE 1 Synthesis of 2-ethyl-l-butanol from 2-ethyl-l-butyraldehyde with aldehyde reductase from Lactococcus lactis.
  • the gene encoding aldehyde reductase from Lactococcus lactis (SEQ ID NO: 3) was cloned into a multicopy plasmid with a N-terminal polyhistidine tag. This plasmid was transformed into E. coli BL21(DE3) for protein production.
  • Protein expression was induced with 1 mM IPTG at an initial optical density at 600 nm (OD) of 0.6. After overnight incubation at 21°C with vigorous agitation (200- 250 rpm), cells were collected by centrifugation for 10 minutes at 4500 rpm and resuspended in 50 mM phosphate buffer (pH 7.5). Protein was extracted by sonication and clarified by centrifugation for 30 min at 8000 rpm. The soluble protein fraction was affinity purified using resins with immobilized nickel or cobalt metal ions and eluted using 300 mM imidazole (in 50 mM phosphate buffer pH 7.5). Purified protein was used for subsequent transformation assays.
  • Enzyme activity was assessed using butyraldehyde or 2-ethyl-butyraldehyde as substrates. Reactions were carried out at 25-37°C in 50 mM phosphate buffer (pH 7.5). Substrate concentration was 0.1-0.5 mM. 1 mM NADH was used as redox cofactor. The reaction was monitored by measuring the decrease in absorbance at 340 nm in a multiplate reader with temperature control. One unit of enzyme activity was defined as the amount of enzyme capable to catalyze the transformation of 1 ⁇ of substrate per minute.
  • the alcohol dehydrogenase of Lactococcus lactis (SEQ ID NO: 1) thus prepared showed a specific activity of 3.9 ⁇ 0.1 mU/mg using 0.1 mM butyraldehyde as substrate and 1 mM NADH as cofactor at 37°C.
  • the alcohol dehydrogenase of Lactococcus lactis thus prepared showed a specific activity of 22 ⁇ 9 mU/mg using 0.1 mM 2-ethyl-butyraldehyde as substrate and 1 mM NADH as cofactor at 37°C.
  • Production of 2-ethyl-butanol from 2-ethyl-butyraldehyde by alcohol dehydrogenase from Z. lactis was confirmed by GC-MS. 0.5 mM 2-ethyl-butyraldehyde and 1 mM NADH in 50 mM phosphate buffer (pH 7.5) were incubated overnight with alcohol dehydrogenase from L. lactis at room temperature.
  • the gene encoding aldehyde reductase from Bacillus stearothermophilus was cloned in a multicopy plasmid with a N-terminal polyhistidine tag. This plasmid was transformed into E. coli BL21(DE3) for protein production.
  • Enzyme activity was assessed using butyraldehyde or 2-ethyl-butyraldehyde as substrates. Reactions were carried out at 25-37°C in 50 mM phosphate buffer (pH 7.5). Substrate concentration was 0.1-0.5 mM. 1 mM NADH was used as redox cofactor. The reaction was monitored by measuring the decrease in absorbance at 340 nm in a multiplate reader with temperature control. One unit of enzyme activity was defined as the amount of enzyme capable to catalyze the transformation of 1 ⁇ of substrate per minute.
  • the alcohol dehydrogenase of B. stearothermophilus (SEQ ID NO: 2) thus prepared showed a specific activity of 11 1 ⁇ 23 mU/mg using 1 mM NADH as cofactor at 37°C and 0.1 mM butyraldehyde as substrate.
  • the alcohol dehydrogenase of B. stearothermophilus thus prepared showed a very low specific activity using 0.1-0.5 mM 2-ethyl-butyraldehyde as substrate and 1 mM NADH as cofactor, which could not be quantified in short term kinetic assays (up to 30 minutes) using spectrophotometric detection of NADH oxidation at 340 nm.
  • Example 3 In vivo biotransformation of 2-ethyl-butyraldehyde into 2-ethyl- butanol with transformed E. coli resting cells
  • E. coli cells transformed with aldehyde reductase expressing plasmids such as those described in this patent are able to biotransform branched aldehydes into the corresponding alcohols.
  • E. coli BL21(DE3)T1 cells transformed with the expression plasmids carrying the genes of the aldehyde reductases described in this patent.
  • Cells are grown in an orbital shaker (operated at 250 rpm) under aerobic conditions in LB growth medium for 2-3 hours or until an absorbance at 600 nm of approximately 0.6 is reached. Cultures are then induced using 1 mM isopropyl-P-D-l- thiogalactopyranoside (IPTG) as inducer and setting temperature to 25°C. After inducing cells for 5 h, cells are harvested by centrifugation at 3000 rpm (5 min at room temperature to avoid damaging the cells).
  • IPTG isopropyl-P-D-l- thiogalactopyranoside
  • Cell pellets obtained were resuspended in a biotransformation medium consisting of phosphate buffer 50 mM, pH 7.5, supplemented with 40 mM glucose and 5 mM 2-ethyl-butyraldehyde. Cell concentration is adjusted to an optical density (absorbance at 600 nm) of around 4.
  • the biotransformation medium is separated from cells by centrifugation at 4500 rpm (15 min). Supernatant is analyzed by GC (preferably coupled to MS detection) in order to determine the 2-ethyl-butyraldehyde to 2-ethyl-butanol biotransformation yield.
  • EXAMPLE 4 In vivo biotransformation of 2-ethyl-butyraldehyde into 2-ethyl- butanol with transformed E. coli growing cells.
  • E. coli cells transformed with aldehyde reductase expressing plasmids such as those described in this patent are able to biotransform branched aldehydes into the corresponding alcohols.
  • E. coli BL21(DE3)T1 cells transformed with the expression plasmids carrying the genes of the aldehyde reductases described in this patent.
  • Cells are grown in an orbital shaker (operated at 250 rpm) under aerobic conditions in LB growth medium for 2-3 hours or until an absorbance at 600 nm of approximately 0.6 is reached. Cultures are then induced using 1 mM isopropyl-P-D-l- thiogalactopyranoside (IPTG) as inducer and setting temperature to 25°C.
  • IPTG isopropyl-P-D-l- thiogalactopyranoside
  • culture medium is supplemented with 40 mM glucose and 5 mM 2-ethyl-butyraldehyde. Cultures are then incubated at 25°C for another 24 to 48 hours under aerobic conditions (in an orbital shaker operated at 250 rpm) or under anaerobic conditions. Cell growth is monitored in all cultures by measuring absorbance of the culture at 600 nm every 1-4 hours.
  • the compound 2-ethyl-l-butanol presents beneficial properties for its use in gasoline formulation that are superior to ethanol, the most spread biocomponent fuel for gasoline.
  • Gasoline properties correspond to EN 228:2013, the European gasoline standard, except for energy density and solubility in water, which are typical values.
  • Table 1 Properties of pure 2-ethyl-l-butanol, pure ethanol, pure iso-butanol and fossil gasoline. Data for ethanol, iso-butanol and fossil gasoline were obtained from the literature. The RON and MON values for 2-ethyl-l- butanol have been determined experimentally using standard procedures. * Vapour pressure in a mixture with hydrocarbons, up to 10% alcohol content.
  • 2-ethly-l-butanol over other alcohols is its relative lower oxygen content, as it only contains one atom of oxygen per 6 atoms of carbon, compared to other alcohol fuels such as ethanol (1 oxygen per 2 carbons) or butanol (1 oxygen per 4 carbons).
  • Density and vapour pressure of 2-ethlyl-l -butanol correspond to a heavy compound in the gasoline mix. This allows for the introduction of light compounds in the gasoline blend, such as light naphtha or butanes, which are often limited due to their high vapour pressure or low density.
  • This example illustrates the suitability of the product 2-ethyl-l-butanol as component for gasoline blends.
  • Table 3 Property values for alcohol molecules Streams representing the conventional blending component and the C6 alcohol was introduced as blending feeds in the "Refinery Blender" model from Process Simulation software Petro-SIM, by KBC. Streams were modelled using the analytical data obtained in the laboratory. The final product (gasoline) specifications were set according to European standard EN 228:2013. The two oxygen content qualities in the specification were simulated: maximum 2.7% m/m content and maximum 3.7% m/m content. Specifications for season classes A and C were simulated, for both oxygen quantity qualities. In total, four specification sets were used. Using the model, formulations for four different gasolines with 2-ethyl-l-butanol as an ingredient were calculated.
  • Gasoline blends were prepared in the laboratory using the refinery samples and 2-ethyl-l-butanol by following the compositions calculated in the model. The different components were refrigerated at 4°C prior to the blending, to avoid losses of the lighter compounds. The blending was performed on a weight basis. Experimental characterization of the gasolines corroborated the calculated properties of the blend, with the exception of two of the blends with highest alcohol content. In these cases, the formulation had to be readjusted for RON and MON specification in order to meet the minimal required specifications.
  • the corrected formulations comprised alcohol contents up to 9.7% in gasolines with 3.7% maximum oxygen content.
  • Final formulations are collected in Table 4.
  • refinery conventional components in this example include ETBE, which is produced at a refinery unit but contains oxygen. Oxygen content in ETBE also accounts for the specification in maximum oxygen content in the final gasoline.
  • Table 4 Formulation of gasolines with 2-ethyl-l-butanol Please note that other formulations are possible, and 2-ethyl-l-butanol blending rates may vary according to the composition of the fossil streams. Naphthas with better gasoline properties, such as isomerate or alkylate, would allow for a higher introduction of 2-ethyl-l-butanol in the gasoline and a decrease in ETBE content.
  • the engine used was a 1.2TSI Volkswagen, from a SEAT Leon 105CV - 77kW vehicle.
  • the power (kW) and the consumption (liters/h) performance were recorded during a test.
  • the engine was set at maximum speed (5000 rpm) and 100% throttle during 25 seconds.
  • the test was repeated three times. Power in samples with alcohols was slightly higher than in conventional gasoline, while consumption was also slightly higher. The differences were negligible, and attributed to the different oxygen content in the samples.
  • Drivability test were also conducted in order to see if the presence of alcohol provoked problems during fast acceleration. Two tests were performed: at 55% throttle and speed between 1000 and 3000 rpm and at 100% throttle and speed between 1000 and 3000 rpm. The tests were performed three times on each fuel sample. No differences with conventional gasoline tests were observed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne d'une manière générale les utilisations de procédés biocatalytiques pour obtenir des alcools à chaîne ramifiée. L'invention concerne également des compositions de carburant comprenant lesdits alcools.
EP15750378.0A 2014-08-14 2015-08-07 Procédé permettant la production d'alcools à chaîne ramifiée Withdrawn EP3180437A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382316 2014-08-14
PCT/EP2015/068295 WO2016023833A2 (fr) 2014-08-14 2015-08-07 Procédé permettant la production d'alcools à chaîne ramifiée

Publications (1)

Publication Number Publication Date
EP3180437A2 true EP3180437A2 (fr) 2017-06-21

Family

ID=51422038

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15750378.0A Withdrawn EP3180437A2 (fr) 2014-08-14 2015-08-07 Procédé permettant la production d'alcools à chaîne ramifiée

Country Status (2)

Country Link
EP (1) EP3180437A2 (fr)
WO (1) WO2016023833A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8431365D0 (en) * 1984-12-12 1985-01-23 Chadwick A T Alcohols
KR100532627B1 (ko) * 2003-05-27 2005-12-02 엔자이텍 주식회사 알코올탈수소효소 생산능을 가지는 미생물과 이를 이용한 광학활성 2-페닐-1-프로파놀의 제조방법
BRPI0922437A2 (pt) * 2008-12-11 2019-09-24 Bio Arch Lab Inc biossíntese de commodities químicas
EP2204453B1 (fr) * 2008-12-30 2013-03-13 Süd-Chemie IP GmbH & Co. KG Processus pour la production de produits chimiques sans cellules

Also Published As

Publication number Publication date
WO2016023833A2 (fr) 2016-02-18
WO2016023833A3 (fr) 2016-04-07

Similar Documents

Publication Publication Date Title
US11821019B2 (en) Biological production of multi-carbon compounds from methane
US8597922B2 (en) Methods and compositions for producing olefins
JP5947219B2 (ja) 低級アルキルアルコールの発酵生産に有用なアルコールデヒドロゲナーゼ（ａｄｈ）
EP3483265B1 (fr) Procédés et compositions pour la production des alcools et aldéhydes gras
CA2652732C (fr) Composants de carburant, compositions de carburant et procedes de fabrication et d'utilisation de ceux-ci
EP2449124B1 (fr) Production d'alcools gras avec des acyl-coa réductases (far) formant des alcools gras
WO2011062987A2 (fr) Procédés et compositions de production d'hydrocarbures
CA2802186A1 (fr) Microorganisme mutant ayant une capacite de production d'hydrocarbures, et procede de production d'hydrocarbures l'utilisant
US9803186B2 (en) Methyl butenol synthase
Brown et al. Alkane biosynthesis in bacteria
EP3180437A2 (fr) Procédé permettant la production d'alcools à chaîne ramifiée
US8669082B1 (en) Single vessel production of butanol from biomass using engineered thermophilic microorganisms
Sommer Fakultät für Chemie Fachgebiet Industrielle Biokatalyse
Charewa Increasing ethanol tolerance through the heterologous expression of the Geobacillus thermoglucosiadius heat-shock proteins (GroEL/GroES) in an Escherichia coli host
Sommer A new synthetic biology methodology for the cell-free production of industrial alcohols
Siemerink Metabolic engineering toward 1-butanol derivatives in solvent producing clostridia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170313

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200303